Decibel Bio
PrivateLast Round
Series A
Mar 5, 2025
Est. Valuation
$109M
Total Funding Raised
$246.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Decibel Bio is an agricultural biotechnology company that develops a proprietary platform to read and write the plant epigenome, enabling real-time trait enhancements for crops without altering their DNA.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Decibel Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Decibel Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 5, 2025 | ||||
| M&A | Sep 25, 2023 | ||||
| IPO Announced | Feb 11, 2021 | ||||
| Series D | Nov 9, 2020 | ||||
| Series C | Jun 19, 2018 | ||||
Series B | Nov 15, 2017 |
Decibel Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series D |
| Janus Henderson Group | Series D |
| Fall Line Capital | Series A |
| Future Ventures | Series A |
| GV | Series C, Series B, Series D |
| OrbiMed | Series D |
| Breakthrough Energy Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors increased 55% MoM.
- Sep 25, 2023
$109M round led by Regeneron Pharmaceuticals.
Decibel Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Decibel Bio's valuation, stock price, and market status.